Lumida
/FIZZ
⌘K
National Beverage Corp

National Beverage Corp

FIZZ
$31.07USD-3.66%-1.18 today

MARKET CAP

2.9B

P/E (TTM)

15.9x

FWD P/E

15.3x

DAY RANGE

$31 – $33

52W RANGE

$30
$48

AI Summary

Stalk
Sell NowHigh

FIZZ sits in a clear Stage 4 decline, trading below all major moving averages under sustained selling pressure. A recent oversold bounce stalled and was rejected at the declining 9EMA/21EMA zone and 50 SMA, confirming resistance. Medium-term bias remains bearish, and timing conditions favor execution now on resistance rejection. We will sell into the EMA/resistance area to participate in the continuation of the downtrend.

  • Shares at $31.20 (52-week low), trading below fair value.
  • Cash position exceeds total debt, bolstering liquidity.
  • Stock down 11.5% past week and 24.7% over last year.
Full analysis →

The case for & against

Bull & Bear analysis

Bearish

National Beverage Corp. (NASDAQ:FIZZ) is a prominent player in the non-alcoholic beverage sector, primarily known for its brands of sparkling water and soft drinks. Positioned within the healthy beverage trend, National Beverage stands out with its notable brands such as LaCroix, appealing to consumers seeking healthy and low-calorie alternatives. Despite recent challenges, it remains an enduring brand with a dedicated customer base aiming to capture an increasing share of the health-conscious market.

Bull says

  • Shares at $31.20 (52-week low), trading below fair value.
  • Cash position exceeds total debt, bolstering liquidity.
  • Added to Russell 2000 Value Index, may draw value investors.
  • Sustains profitability despite headwinds (positive EBITDA margins).
  • Strong balance-sheet resilience (QS Score ~0.69) and favorable book-to-price.
  • LaCroix brand taps growing health-conscious sparkling water trend.

Bear says

  • Stock down 11.5% past week and 24.7% over last year.
  • Negative earnings yield (~-16%) suggests cash flow strain.
  • UBS issues Strong Sell rating with $33 price target.
  • Rising input costs forecast to squeeze margins into FY27.
  • High short interest and low institutional ownership indicate skepticism.
  • Poor growth outlook and downward estimate revisions heighten risk.